Executive Vice President, Human Resources · ABBOTT LABORATORIES (ABT)

Stephen Fussell

FY2018 is the first fiscal year CompBrief holds for Stephen Fussell as a named executive officer of ABBOTT LABORATORIES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$6,838,636

Salary $620,000Stock awards $2,691,621

5th of 6 named executive officers at Abbott Laboratories by FY2018 total.

6 named officers on file for ABBOTT LABORATORIES, FY2018

Stephen Fussell’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • ABT’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ABBOTT LABORATORIES’s whole pay program stands against its peers

  • ABBOTT LABORATORIES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 15, 2019 (DEF 14A).

Free

Get Stephen Fussell’s full pay file as a PDF — free

More than this page: up to 10 years of Stephen’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Stephen Fussell compensation by year

ABBOTT LABORATORIES Summary Compensation Table · the one fiscal year held
In US dollars, as ABBOTT LABORATORIES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$620,000
Bonus$0
Stock awards$2,691,621
Option awards$2,691,897
Non-equity incentive$682,000
Pension and deferred compensation$55,339
All other$97,779
Total$6,838,636

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABBOTT LABORATORIES DEF 14A filed March 15, 2019, accession 0001047469-19-001316, and prior-year filings.

How this page was built: the ABBOTT LABORATORIES filed document, accession 0001047469-19-001316. Every figure is read from that document and cited to the page and table it appears in. Filed March 15, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU44,909$3,248,268—
RSU17,568$1,270,693—
RSU11,936$863,331—
Option104,642—$38.40
Option246,963—$59.94
Option121,494—$44.40

Per the Outstanding Equity Awards at Fiscal Year-End table in ABBOTT LABORATORIES's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

ABBOTT LABORATORIES’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Miles WhiteAbbott's Chairman of the Board and Chief Executive Officer$24,254,238
Robert FordPresident and Chief Operating Officer$8,127,252
Brian YoorExecutive Vice President, Finance and Chief Financial Officer$7,612,836
Hubert AllenExecutive Vice President, General Counsel and Secretary$7,317,776
Stephen Fussell · this pageExecutive Vice President, Human Resources$6,838,636
Daniel SalvadoriExecutive Vice President, Nutritional Products$5,954,210

The full ABBOTT LABORATORIES compensation record

free company brief

This page is one person within ABBOTT LABORATORIES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ABBOTT LABORATORIES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABBOTT LABORATORIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stephen Fussell's compensation dossier · One-time report. No refunds.